Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis-Reference-Cited by-同舟云学术

Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis

Published:2015-06 Issue:6 Volume:67 Page:1112-1121
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Hamoen Esther H.J.,de Rooij Maarten,Witjes J. Alfred,Barentsz Jelle O.,Rovers Maroeska M.

Publisher

Elsevier BV

Subject

Urology

Reference33 articles.

1. Cancer treatment and survivorship statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging;Delongchamps;BJU Int,2011

3. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer;Vilanova;Am J Roentgenol,2011

4. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging;Kitajima;J Magn Reson Imaging,2010

5. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4–10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging;Tamada;Am J Roentgenol,2011

Cited by 274 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiparametric magnetic resonance imaging and magnetic resonance imaging fusion-guided biopsy for the diagnosis of prostate cancer: current status;Digital Diagnostics;2024-09-11

2. Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions;Prostate Cancer and Prostatic Diseases;2024-07-24

3. Enhancing prostate cancer diagnosis and reducing unnecessary biopsies with [18F]DCFPyL PET/CT imaging in PI-RADS 3/4 patients;Scientific Reports;2024-07-05

4. Prostate cancer epidemiology and prognostic factors in the United States;Frontiers in Oncology;2023-10-12

5. Application of targeted diagnosis of PSMA in the modality shift of prostate cancer diagnosis: a review;Frontiers in Oncology;2023-09-01